Billionaire Profile
Vivek Ramaswamy
Global Rank
#1707

Image: Gage Skidmore | CC BY-SA 3.0 | via Wikimedia Commons

Vivek Ramaswamy

CEO, Investments
UNITED STATES
Real-Time Net Worth
$2.422B
Estimated based on Investments stock value as of March 6, 2026
+0.54% (24h)
Age
40
Source
investments
Industry
finance-investments
Citizenship
UNITED STATES

Biography

Vivek Ramaswamy is an American entrepreneur, author, and political figure. Born on August 9, 1985, Ramaswamy is known for founding Roivant Sciences, a biotech company. His early career included work in hedge funds before transitioning to entrepreneurship. Ramaswamy's wealth source is primarily investments, stemming from his founding of Roivant Sciences and his stake in Strive Asset Management. He gained further prominence as a candidate in the 2024 Republican presidential primary, later endorsing Donald Trump. As of November 2025, his net worth is approximately $1.8 billion, making him one of the youngest billionaires in the country.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Vivek Ganapathy Ramaswamy was born in Cincinnati, Ohio, on August 9, 1985. His parents immigrated from India. His mother worked as a geriatric psychiatrist, and his father was an engineer and patent lawyer. Ramaswamy was raised in Ohio and attended a Jesuit high school, graduating as valedictorian. He was also a nationally ranked junior tennis player.

Education and Early Career

Ramaswamy graduated summa cum laude from Harvard University with a bachelor's degree in biology in 2007. He then earned a J.D. degree from Yale Law School in 2013. Before founding Roivant Sciences, he worked as a successful biotech investor at a hedge fund. At Yale Law School, he befriended fellow Ohio native and future vice president of the United States JD Vance. Ramaswamy said in 2023 that he had a net worth of around $15 million before graduating from law school.

Rise to Success

In 2014, at age 29, Ramaswamy founded Roivant Sciences, a biotechnological pharmaceutical company. The company focused on acquiring and developing overlooked pharmaceuticals. In 2020, Sumitomo Dainippon purchased a portfolio of five Roivant drugs and a 10% company stake for $3 billion. This sale provided Ramaswamy with an estimated $176 million in capital gains. Roivant Sciences went public in 2021. In 2023, Roivant's stock rose, increasing the value of Ramaswamy's holdings. He also co-founded the investment firm, Strive Asset Management, in 2022.

Political Career

Ramaswamy entered national politics as a presidential candidate in the 2024 Republican primaries. He withdrew his bid and endorsed Donald Trump for the 2024 presidential election. Ramaswamy was appointed as co-lead of President-elect Trump's new Department of Government Efficiency alongside Elon Musk. He is currently running for Governor of Ohio in 2026.

Philanthropy

Ramaswamy serves on the board of directors of the Philanthropy Roundtable.

Career Milestones

2007

Graduated from Harvard University

Received a bachelor's degree in biology.

2013

Graduated from Yale Law School

Earned a J.D. degree.

2014

Founded Roivant Sciences

Established a biotechnological pharmaceutical company.

2020

Sale of Roivant Drugs to Sumitomo Dainippon

Sumitomo Dainippon purchased a portfolio of Roivant drugs and a 10% stake in the company.

2021

Founded Strive Asset Management

Co-founded an investment firm.

2023

Announced Presidential Candidacy

Declared his candidacy for the 2024 Republican presidential primary.

2024

Appointed co-lead of Department of Government Efficiency

Appointed by Donald Trump to lead the Department of Government Efficiency.

Philanthropy & Social Impact

Board Member

Philanthropy Roundtable Board Member

Undisclosed

Serves on the board of directors.